Profile
Jeanne Y.
Jew worked as a Director at Catalyst Biosciences, Inc. from 2021 to 2022.
Prior to that, she held positions as a Principal at Genentech, Inc. and Scios, Inc. From 2002 to 2007, she served as the VP-Corporate & Commercial Development at Onyx Pharmaceuticals, Inc. Before that, she was the Vice President-Business Development at Coulter Pharmaceuticals, Inc. from 1997 to 2001.
She also held the position of Vice President-Business Development at Deltagen, Inc. from 2001 to 2002.
From 2008 to 2015, she worked as the Senior Vice President-Business Development at Humanigen, Inc. and from 2015 to 2020, she held the same position at Paratek Pharmaceuticals, Inc. Currently, she is the Chief Business Officer at ALX Oncology Holdings, Inc. Ms. Jew holds an MBA from Cornell University and an undergraduate degree from Wesleyan University.
Former positions of Jeanne Jew
| Companies | Position | End |
|---|---|---|
| CATALYST BIOSCIENCES | Director/Board Member | 2022-12-25 |
| PARATEK PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2020-02-29 |
| HUMANIGEN, INC. | Corporate Officer/Principal | 2015-06-30 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | - |
| DELTAGEN INC. | Corporate Officer/Principal | 2002-10-31 |
Training of Jeanne Jew
| Cornell University | Masters Business Admin |
| Wesleyan University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| DELTAGEN INC. | Commercial Services |
| HUMANIGEN, INC. | Health Technology |
| PARATEK PHARMACEUTICALS, INC. | Health Technology |
| ALX ONCOLOGY HOLDINGS INC. | Health Technology |
| Private companies | 5 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Coulter Pharmaceuticals, Inc.
 Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 1995, Coulter Pharmaceutical is engaged in the development of novel drugs and therapies for the treatment of people with cancer and autoimmune diseases. Currently under development is a family of therapeutics based upon two drug discovery platforms: therapeutic antibodies and targeted oncologics. | Health Technology |
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Catalyst Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Jeanne Jew
